Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Myobloc (rimabotulinumtoxinB) for the Treatment of Chronic Sialorrhea

Drug Name

Myobloc® (rimabotulinumtoxinB)

Developer

US WorldMeds/Elan Corporation

Therapy Class

Neurotoxin

Product Description

Botulinum toxin Type B

Current Indication

Chronic sialorrhea, cervical dystonia

Market Sector

Ear nose throat (ENT)

Development Status

Approved in the US, Canada, Europe, and Japan
Expand
Close
Close
Close

Go Top